Delivery Order SPE2DB20D1100-SPE2DB25FE6K7
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,921.01, is for the delivery of Omega-3 Ethyl Esters 1 GM CAP 120S, a dietary supplement. This order is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,649.08 firm fixed price delivery order is for the supply of 4560713982 OMEGA-3 ETHYL ESTERS 1 GM CAP 120S. The contract has an ultimate completion date of April 26, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,579.50 delivery order is for the supply of 4556919033 OMEGA-3 ETHYL ESTERS 1 GM CAP 120S, with an ultimate completion date of April 19, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Icosapent Ethyl 1 Gram Capsule (120-count packages) with a ceiling value of $1,779.42. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract calls for performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,589.52 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Icosapent Ethyl 1 Gram Capsule (120-count units). This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of August 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,871.58 firm fixed-price delivery order is for the supply of 120-count capsules of the drug Icosapent Ethyl 1 gram. The contract has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S. The firm-fixed-price Delivery Order, valued at $1,138.43, has a completion date of May 9, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,374.04 firm fixed-price delivery order is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,657.92 Firm Fixed Price Delivery Order is for the supply of Icosapent Ethyl 1 gram capsules, a prescription medication, with a period of performance through August 16, 2024. The award is not associated with a set-aside program. As a significant federal contractor, Amerisourcebergen provides a wide range of pharmaceutical products and medical...
- This federal contract award from the Defense Logistics Agency (DLA) is a $2,668.69 firm-fixed price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 120-count capsules of Icosapent Ethyl, a cardiovascular medication. The award is not designated under any set-aside program. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE6K7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,204.88 to AmerisourceBergen Drug Corp for Omega-3 Ethyl Esters 1 GM capsules (120-count) on September 12, 2025, with completion scheduled for September 15, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's extensive contract portfolio demonstrates its capability to fulfill diverse federal medical procurement requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/12/25 |